OBS Group Completes 6th Acquisition
September 17, 2021- International Pharmaceutical News: OBS Group Completes 6th Acquisition in Pakistan
COOPER PHARMA and OSI
August 11, 2021- COOPER PHARMA and OSI Sign Distribution Agreement to protect and prevent against respiratory viruses including the one that causes COVID-19
OSI
April 22, 2021- Oral Science International Engages The Harel Group to Search for Strategic Partners Globally
YAMA+
June 15, 2020- Yama+ Engages The Harel Group to Search for Strategic Partners Globally
ICECURE
May 27, 2020- IceCure Medical Engages The Harel Group to Search for Distributors in the US and Europe
BIOHOPE
February 14, 2020- Biohope Engages The Harel Group to search for strategic partners to commercialize Immunobiogram in Japan and Brazil.
EXAGEN
April 29, 2019- Exagen Engages The Harel Group to search for strategic partners to develop and/or commercialize a portfolio of innovative testing products under the umbrella brand, AVISE, in Japan.
POLYPID
Dec 21, 2017- PolyPid Appoints Jacob Harel as Chairman of the Board of Directors
EMERALD
April 02, 2017- Emerald Engages The Harel Group to search for global strategic partners to support the commercialization of Emerald's DermaCompare product.
G&W
March 13, 2017- G&W Engages The Harel Group to identify and gain access to new business opportunities through acquisition and/or collaboration transactions to accelerate Company growth.
VIANEX
January 27, 2017- Vianex Engages The Harel Group to support various business development initiatives and to expand their operation in international markets.
SUPHERB
January 6, 2017- SupHerb will be working with The Harel Group to identify commercial partners in international markets for their Vitamins, Minerals and Supplements (VMS) as well as for their unique delivery technologies.
MORAZ
February 18th, 2016 - Moraz Engages The Harel Group to Search for Strategic Partners in International Markets.
NAVEH PHARMA
September 10, 2015 - Naveh Pharma and The Harel Group to Search for Strategic Partners in International Markets.
SIDRAPEX
May 5, 2015 - Sidrapex and The Harel Group sign Cooperation Agreement to Facilitate jointly Pharmaceutical and Medical Devices Licensing Arrangements between Global Innovative Companies and Leading Pharmaceutical Companies in South & South-East Asia.
THERAPIX BIOSCIENCES
March 30, 2015 - Therapix Biosciences Engages The Harel Group to Search for Strategic Partners for the Development and Commercialization of its Unique Synthetic Cannabinoid-Based Therapies in International Markets.
ADIAL PHARMACEUTICALS
February 16, 2015 - ADial Pharmaceuticals Engages The Harel Group to Search for Strategic Partner for ADial in International Markets.
INSULINE MEDICAL
February 13, 2015 - Insuline Medical Appoints Jacob Harel to its Board of Directors.
EMSA HEALTHCARE
February 8, 2015 - EMSA Healthcare and The Harel Group sign Cooperation Agreement to facilitate jointly Pharmaceutical and Medical Devices Licensing Arrangements between global innovative companies and Pharmaceutical companies in China.
MEDIWOUND LTD.
January 31, 2015 - MediWound Ltd. Will be working with The Harel Group to Identify Commercial Partners for NexoBrid® in International Markets.
TRIS PHARMA
January 19, 2015 - The Harel Group to Support Tris Pharma in its Commercialization of Tris products in International Markets.
EXELA PHARMA SCIENCES
January 08, 2015 - Exela Pharma Sciences Engages The Harel Group to Identify Commercial Partners for Exela products in International Markets
DEXCEL PHARMA
December 21, 2014 - Dexcel Pharma and The Harel Group to Collaborate on the Commercialization of Dexcel products in Emerging Markets.